Published online Jan 21, 2016. doi: 10.3748/wjg.v22.i3.1213
Peer-review started: June 11, 2015
First decision: July 20, 2015
Revised: August 17, 2015
Accepted: November 9, 2015
Article in press: November 9, 2015
Published online: January 21, 2016
Processing time: 220 Days and 0.7 Hours
Gastric cancer is a leading cause of cancer-related deaths. However, the mechanisms underlying gastric carcinogenesis remain largely unclear. The association of non-coding RNAs (ncRNAs) with cancer has been widely studied during the past decade. In general, ncRNAs have been classified as small ncRNAs, including microRNAs (miRNAs), and long non-coding RNAs (lncRNAs). Emerging evidence shows that miRNAs and lncRNAs play key roles in the formation and progression of many cancers. In this review, we focus on the regulation of miRNAs and lncRNAs in gastric cancer. miRNAs and lncRNAs appear to be involved in gastric tumor growth, invasion, and metastasis and in establishment of the gastric tumor microenvironment through various mechanisms. Furthermore, we also discuss the possibilities of establishing miRNAs and lncRNAs as potential biomarkers and therapeutic targets for gastric cancer. Taken together, we summarize the emerging roles of ncRNAs in gastric cancer development and their possible clinical significance.
Core tip: Non-coding RNAs (ncRNAs) are recognized as an important player in multiple physiological and pathological processes through diverse mechanisms. This review summarizes the current knowledge on dysregulation of microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) in gastric tumor growth, invasion and metastasis. Moreover, the possibilities of targeting miRNAs and lncRNAs in gastric cancer diagnosis, prognosis and treatment are also discussed.